BD and Opentrons Collaborate on Robotic Automation for Single-Cell Multiomics

October 08, 2025
BD and Opentrons have announced a multi-year collaboration to integrate robotic automation into BD's single-cell multiomics instruments, enhancing disease research and drug development.

BD (Becton, Dickinson and Company) and Opentrons Labworks, Inc. have announced a multi-year collaboration to integrate robotic liquid-handling capabilities into BD's single-cell multiomics instruments. This partnership aims to automate critical experimental steps, thereby accelerating and scaling disease research and drug development announced in a press release.

The collaboration will see the integration of the BD Rhapsody™ System with the Opentrons Flex® platform, allowing scientists to perform hands-free workflows in their single-cell multiomics experiments. A key aspect of this partnership is the development of an automation-compatible module for the BD Rhapsody™ System, which will automate next-generation sequencing library preparation and cell capture.

Early access opportunities for interested labs will soon be available, with more information provided at the upcoming American Society of Human Genetics Annual Meeting in Boston from October 14-18, 2025.

We hope you enjoyed this article.

Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.

Also, consider following us on social media:

Healthcare & Life Sciences AI AI Brief AI Brief (X)

More from: Life Sciences

12/03
FDA Introduces Agentic AI Platform for Staff Workflows
12/03
Medint Study Finds AI Misses Key Nuances in Complex Clinical Decisions
12/03
Linus Health to Present AI Tools for Early Alzheimer’s Detection at CTAD 2025
12/03
Dastify Solutions Report Predicts 40% Drop in Medical Claim Denials with AI in 2025
12/03
Dastify Solutions Report Predicts 40% Reduction in Medical Claim Denials Through AI in 2025

Subscribe to Life AI Weekly

Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.

AI Token Webinar

Industry analysis

2025 Global Business Services Agenda: Gen AI Takes Center Stage

The Hackett Group

This industry analysis by The Hackett Group explores the transformative impact of generative artificial intelligence (Gen AI) on global business services (GBS) in 2025. The study highlights the shift from exploration to acceleration of Gen AI initiatives, with 89% of executives advancing these projects to improve customer satisfaction, innovate products, and reduce costs. The report also discusses the challenges and strategies for successful Gen AI adoption, emphasizing the need for a technology-enabled operating model and the importance of reskilling the workforce.

Read more

You May Also Like